Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000906344-09-000257
Filing Date
2009-02-11
Accepted
2009-02-11 17:25:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G-A2 (2-11-09) pluristemtherapeutics_13g-a1.htm SC 13G/A 60535
  Complete submission text file 0000906344-09-000257.txt   62512
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Subject) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-78785 | Film No.: 09590775
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address (415) 677-1577
Levine Mitchell S (Filed by) CIK: 0001383492 (see all company filings)

Type: SC 13G/A